The activation of constituents such as Atrogin-1 and MuRF-1 of E3 accelerates the substrate ubiquitination, improves protein degradation in proteasomes, and enhances the atrophy and loss of lean body mass, such as skeletal muscle, which finally leads to cancer cachexia [27]. This evidence concerns the gene FBXO32 and Cachexia.